TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV) plus malignancies-MedSci.cn

TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV) plus malignancies

Le Tourneau, C; Cassier, P; Rolland, F; Salas, S; Limacher, JM; Capitain, O; Lantz, O; Lalanne, A; Ekwegbara, C; Tavernaro, A; Makhloufi, H; Bendjama, K; Delord, JP

ANNALS OF ONCOLOGY, 2020; 31 (): S1442

科室
- - 订阅+
  - 更多科室
工具
服务